Flexion Therapeutics, Inc

(NASDAQ:FLXN)

Latest On Flexion Therapeutics, Inc (FLXN):

Date/Time Type Description Signal Details
2021-10-24 00:50 ESTNewsFlexion Therapeutics: Bullish On The BuyoutN/A
2021-10-16 07:43 ESTNewsJasper more than doubles while M&A headlines weekly healthcare performersN/A
2021-10-12 05:59 ESTNewsFlexion Therapeutics draws downgrade following 'disappointing' Pacira buyoutN/A
2021-10-11 11:12 ESTNewsPacira Therapeutics acquires Flexion Therapeutics for $8.50 per share in cash plus one CVRN/A
2021-08-25 17:17 ESTNewsFlexion Therapeutics expands early-stage FX301 post-operative pain management trialN/A
2021-08-10 03:57 ESTNewsFlexion Therapeutics shares rise on mid-stage ZILRETTA osteoarthritis study resultsN/A
2021-08-06 23:38 ESTNewsFlexion Therapeutics, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-05 04:42 ESTNewsFlexion Therapeutics EPS beats by $0.06, misses on revenue; reiterates guidanceN/A
2021-08-05 04:41 ESTNewsFlexion Therapeutics, Inc. (FLXN) CEO Michael Clayman on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-22 23:33 ESTNewsFlexion Therapeutics: Sector Sell-Off Provides Opportunity To Reload At A DiscountN/A
2021-07-21 09:01 ESTNewsFlexion Therapeutics names William Andrews as chief medical officerN/A
2021-07-21 08:39 ESTNewsMRIN, ALT, FLXN and FULC among after-hours moversN/A
2021-07-21 08:25 ESTNewsFlexion Therapeutics adds Utpal Koppikar to its board of directorsN/A
2021-05-04 19:24 ESTNewsIt's Time To Buy Flexion Therapeutics As Revenue Is Expected To GrowN/A
2021-04-28 14:27 ESTNewsFlexion Therapeutics' FX201 shows encouraging action in knee osteoarthritisN/A
2021-04-14 07:39 ESTNewsFlexion Therapeutics trades high on Q1 prelim revenue, FY21 guidanceN/A
2021-03-31 21:07 ESTNewsFlexion Therapeutics treats first patient in early-stage FX301 trialN/A
2021-03-29 10:38 ESTNewsThe Right Call On Frustrating Flexion TherapeuticsN/A
2021-03-26 08:57 ESTNewsAspira extends gains as analysts weigh in; Flexion to benefit from Pfizer’s failure in osteoarthritis drug and more in today’s analyst actionN/A
2021-03-17 00:20 ESTNewsFlexion Therapeutics, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-03-12 07:41 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 03:43 ESTAnalyst RatingThe Analyst Target Price has decreased from $20.69 to $20.38.Neutral
2021-03-11 07:00 ESTNewsFlexion Therapeutics EPS beats by $0.10, misses on revenueN/A
2021-03-11 07:00 ESTNewsFlexion Therapeutics, Inc. (FLXN) CEO Michael Clayman on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-11 03:38 ESTEarnings EstimateAn EPS average of -$0.50 is estimated for the 2022 year.Sell
2021-03-11 03:38 ESTEarnings EstimateAn EPS average of -$0.48 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-01 17:23 ESTNewsFlexion shares gain 4% on FDA clearance of FX301 in post-operative painN/A
2021-02-26 15:35 ESTAnalyst RatingThe Analyst Target Price has increased from $20.17 to $20.69.Buy
2021-01-28 03:53 ESTAnalyst RatingThe Analyst Target Price has decreased from $20.25 to $20.17.Neutral
2021-01-21 04:01 ESTAnalyst RatingThe Analyst Target Price has increased from $18.91 to $20.25.Buy
2021-01-17 19:34 ESTNewsFlexion Therapeutics: Fighting Through COVID-19 HeadwindsN/A
2021-01-15 03:38 ESTAnalyst RatingThe Analyst Target Price has decreased from $19.18 to $18.91.Neutral
2021-01-14 03:39 ESTAnalyst RatingThe Analyst Target Price has increased from $18.91 to $19.18.Buy
2021-01-13 13:31 ESTNewsFlexion Therapeutics anticipates Q4 Zilretta sales of $26.3MN/A
2020-12-30 03:44 ESTAnalyst RatingThe Analyst Target Price has decreased from $20.25 to $18.91.Neutral
2020-11-26 20:02 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 07:56 ESTAnalyst RatingThe Analyst Target Price has decreased from $20.5 to $20.25.Neutral
2020-11-07 15:51 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 19:43 ESTAnalyst RatingThe Analyst Target Price has decreased from $20.58 to $20.5.Neutral
2020-11-06 11:45 ESTFinancialsCompany financials have been released.Neutral
2020-11-05 19:43 ESTEarnings EstimateAn EPS average of -$0.52 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-05 04:26 ESTNewsFlexion Therapeutics EPS beats by $0.01, beats on revenueN/A
2020-10-30 13:07 ESTAnalyst RatingThe Analyst Target Price has decreased from $20.75 to $20.58.Neutral
2020-10-15 16:50 ESTNewsFlexion Therapeutics (FLXN) Presents Q3 Commercial Metrics - SlideshowN/A
2020-10-15 00:46 ESTAnalyst RatingThe Analyst Target Price has increased from $20.5 to $20.75.Buy
2020-10-14 13:13 ESTNewsFlexion Therapeutics rallies on ZILRETTA net salesN/A
2020-10-14 00:47 ESTAnalyst RatingThe Analyst Target Price has decreased from $20.67 to $20.5.Neutral
2020-10-06 11:14 ESTNewsFlexion's peripheral nerve blocker shows encouraging action preclinical studiesN/A
2020-09-26 12:47 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:54 ESTFinancialsCompany financials have been released.Neutral

About Flexion Therapeutics, Inc (FLXN):

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions in the United States. The company offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) knee pain. It is also involved in the development of FX201, a gene therapy product candidate designed to provide on demand production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, a NaV1.7 inhibitor for the management of post-operative pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts.

FLXN Quotes by TradingView

See Advanced Chart

General

  • Name Flexion Therapeutics, Inc
  • Symbol FLXN
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 257
  • Fiscal Year EndDecember
  • IPO Date2014-02-12
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.flexiontherapeutics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 6.23
  • Price/Book (Most Recent Quarter) 35.62
  • Enterprise Value Revenue 7.57
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.74
  • Next Year EPS Estimate -$0.60
  • Next Quarter EPS Estimate -$0.57
  • Profit Margin -133%
  • Operating Margin -109%
  • Return on Assets -25%
  • Return on Equity -6257%
  • Revenue 85.55 million
  • Earnings Per Share -$4.28
  • Revenue Per Share $1.9
  • Gross Profit 66.53 million
  • Quarterly Earnings Growth 11.2%
View More

Highlights

  • Market Capitalization 547.17 million
  • EBITDA -150407008
  • Analyst Target Price $20.38
  • Book Value Per Share $0.34
View More

Share Statistics

  • Shares Outstanding 49.92 million
  • Shares Float 45.5 million
  • % Held by Insiders 434%
  • % Held by Institutions 104.39%
  • Shares Short 8.16 million
  • Shares Short Prior Month 8.19 million
  • Short Ratio 14.58
  • Short % of Float 22%
  • Short % of Shares Outstanding 17%
View More

Technicals

  • Beta 1.49
  • 52 Week High $14.39
  • 52 Week Low $5.35
  • 50 Day Moving Average 11.74
  • 200 Day Moving Average 11.71
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Flexion Therapeutics, Inc (FLXN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Flexion Therapeutics, Inc (FLXN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$26.31 million-$0.32-$0.4528.7%
2020-09-302020-11-04$N/A-$0.50-$0.511.96%
2020-06-302020-08-05$N/A-$0.76-$0.67-13.86%
2020-03-312020-05-07$N/A-$0.95-$0.994.41%
2019-12-312020-03-12$23.65 million-$0.87-$0.958.31%
2019-09-302019-11-07$21.79 million-$1.00-$0.95-5.11%
2019-06-302019-08-06$16.95 million-$0.96-$1.058.25%
2019-03-312019-05-08$10.56 million-$1.09-$1.08-0.93%
2018-12-312019-02-28$9.54 million-$1.07-$1.178.74%
2018-09-302018-11-07$6.99 million-$1.15-$1.203.9%
2018-06-302018-08-07$3.8 million-$1.16-$1.235.61%
2018-03-312018-05-08$2.19 million-$1.10-$1.3317.5%
2017-12-312018-03-08$355000-$1.43-$1.13-27.11%
2017-09-302017-11-06$N/A-$1.07-$0.99-8.49%
2017-06-302017-08-08$N/A-$0.91-$0.83-9.45%
2017-03-312017-05-04$N/A-$0.75-$0.73-2.94%
2016-12-312017-03-09$N/A-$0.78-$0.72-8.89%
2016-09-302016-11-07$N/A-$0.65-$0.63-3.17%
2016-06-302016-08-03$N/A-$0.63-$0.687.35%
2016-03-312016-05-12$N/A-$0.78-$0.61-27.51%
2015-12-312016-03-10$N/A-$0.63-$0.58-8.3%
2015-09-302015-11-09$N/A-$0.52-$0.6013.33%
2015-06-302015-08-06$N/A-$0.58-$0.54-7.41%
2015-03-312015-05-07$N/A-$0.43-$0.5623.21%
2014-12-312015-03-23$N/A-$0.47-$0.5311.32%
2014-09-302014-11-13$N/A-$0.45-$0.5518.18%
2014-06-302014-08-07$N/A-$0.38-$0.5226.92%
2014-03-312014-05-08$N/A-$0.86-$0.52-65.38%
2013-12-312014-03-28$N/A-$4.65-$0.51-811.76%

Flexion Therapeutics, Inc (FLXN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 10.59 million N/A N/A N/A 17.07 million
Income Before Tax -19.65 million N/A N/A N/A -33.52 million
Selling General Administrative 23.66 million N/A N/A N/A 32.1 million
Gross Profit 19.95 million N/A N/A N/A 19.58 million
Ebit -14.47 million N/A N/A N/A -29.59 million
Operating Income -14.3 million N/A N/A N/A -29.59 million
Income Tax Expense -1000 248000 248000 N/A N/A
Total Revenue 26.31 million N/A N/A N/A 23.65 million
Cost of Revenue 6.36 million N/A N/A N/A 4.08 million
Total Other Income Expense Net N/A N/A N/A N/A -3.92 million
Net Income From Continuing Operations -19.65 million N/A N/A N/A -33.52 million
Net Income Applicable to Common Shares -19.65 million -24.64 million -32.62 million -36.8 million -33.52 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A 33.7 million 43.09 million
Change to Liabilities 5.85 million 495000 -3.04 million 2.28 million -305000
Total Cash Flow from Investing Activities -42.04 million -6.58 million 37.95 million 30.93 million 43.04 million
Net Borrowings N/A N/A 20 million N/A 30.63 million
Total Cash Flow from Financial Activities N/A N/A N/A 2.5 million 30.48 million
Change to Operating Activities 3.48 million -4.96 million 167000 -5.03 million 7.93 million
Change in Cash N/A N/A N/A -5.52 million 42.07 million
Total Cash from Operating Activities -12.21 million -20.41 million -28.2 million -38.94 million -31.45 million
Depreciation N/A N/A N/A 721000 687000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A -1.52 million -1.64 million
Change to Account Receivables N/A N/A N/A -7.8 million -6.73 million
Other Cash Flow from Financing Activities -293000 -107000 N/A N/A -161000
Change to Net Income 4.7 million 3.96 million 4.96 million 3.72 million 4.52 million
Capital Expenditures N/A N/A N/A 2.78 million 50000
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 268.59 million N/A N/A N/A 237.67 million
Total Stockholder Equity -16.66 million N/A N/A N/A -20.11 million
Other Current Liabilities 11.53 million 10 million N/A N/A N/A
Total Assets 251.93 million N/A N/A N/A 217.56 million
Common Stock 49000 49000 49000 39000 38000
Other Current Assets 5.11 million N/A N/A N/A N/A
Retained Earnings -782.31 million -762.66 million -738.02 million -705.4 million -668.6 million
Other Liabilities N/A 295000 295000 295000 251000
Other Assets N/A N/A N/A N/A N/A
Cash 107.7 million N/A N/A N/A 82.25 million
Total Current Liabilities 55.27 million 50.88 million N/A N/A 36.22 million
Other Stockholder Equity -11000 -6000 3000 6000 62000
Property, Plant & Equipment 19.54 million 26.3 million 25.21 million 23.19 million 21.89 million
Total Current Assets 225.81 million 237.07 million N/A N/A 195.68 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets -16.66 million -3.1 million 16.52 million -52.31 million -20.11 million
Short Term Investments 67.58 million N/A N/A N/A 54.41 million
Long Term Debt 206.9 million N/A N/A N/A 193.59 million
Inventory 15.39 million 17.95 million N/A N/A 16.53 million
Accounts Payable 26.94 million 7.23 million N/A N/A 15.26 million

Flexion Therapeutics, Inc (FLXN) Chart:

Flexion Therapeutics, Inc (FLXN) News:

Below you will find a list of latest news for Flexion Therapeutics, Inc (FLXN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Flexion Therapeutics, Inc (FLXN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Flexion Therapeutics, Inc (FLXN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120038731/0001209191-20-038731-index.htm
2020-09-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1419600/000000000020008732/0000000000-20-008732-index.htm
2019-01-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000007297119000119/0000072971-19-000119-index.htm
2019-05-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000007297119000265/0000072971-19-000265-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000009375119000297/0000093751-19-000297-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000009375120000574/0000093751-20-000574-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000021545719004033/0000215457-19-004033-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000081413320000019/0000814133-20-000019-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000083423720005233/0000834237-20-005233-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000108514619000807/0001085146-19-000807-index.htm
2019-04-23SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000108514619001235/0001085146-19-001235-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000108514620000805/0001085146-20-000805-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000110465920021004/0001104659-20-021004-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000114420419007430/0001144204-19-007430-index.htm
2019-02-15SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000114420419008517/0001144204-19-008517-index.htm
2019-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000119312519323480/0001193125-19-323480-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000119312520147274/0001193125-20-147274-index.htm
2020-05-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1419600/000119312520147375/0001193125-20-147375-index.htm
2020-05-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1419600/000119312520148673/0001193125-20-148673-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000119312520148678/0001193125-20-148678-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919118040937/0001209191-18-040937-index.htm
2018-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919118046129/0001209191-18-046129-index.htm
2018-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919118046163/0001209191-18-046163-index.htm
2018-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919118054524/0001209191-18-054524-index.htm
2018-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919118054525/0001209191-18-054525-index.htm
2018-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919118054551/0001209191-18-054551-index.htm
2018-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919118058085/0001209191-18-058085-index.htm
2018-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919118058086/0001209191-18-058086-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119002065/0001209191-19-002065-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119002070/0001209191-19-002070-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119002077/0001209191-19-002077-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119002079/0001209191-19-002079-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119002084/0001209191-19-002084-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119002087/0001209191-19-002087-index.htm
2019-01-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119004671/0001209191-19-004671-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119016478/0001209191-19-016478-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119016492/0001209191-19-016492-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119016498/0001209191-19-016498-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119016506/0001209191-19-016506-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119016512/0001209191-19-016512-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119016755/0001209191-19-016755-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119016930/0001209191-19-016930-index.htm
2019-03-054/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119017155/0001209191-19-017155-index.htm
2019-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119019135/0001209191-19-019135-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119028497/0001209191-19-028497-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119029182/0001209191-19-029182-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119029970/0001209191-19-029970-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119032582/0001209191-19-032582-index.htm
2019-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119033898/0001209191-19-033898-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119038447/0001209191-19-038447-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119038454/0001209191-19-038454-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119038458/0001209191-19-038458-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119038459/0001209191-19-038459-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119038460/0001209191-19-038460-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119038461/0001209191-19-038461-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119038463/0001209191-19-038463-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119038758/0001209191-19-038758-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119038759/0001209191-19-038759-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119038761/0001209191-19-038761-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119038762/0001209191-19-038762-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119038817/0001209191-19-038817-index.htm
2019-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119045123/0001209191-19-045123-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119045325/0001209191-19-045325-index.htm
2019-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119045884/0001209191-19-045884-index.htm
2019-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119047709/0001209191-19-047709-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119052748/0001209191-19-052748-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119052753/0001209191-19-052753-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119052754/0001209191-19-052754-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119052756/0001209191-19-052756-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919119052757/0001209191-19-052757-index.htm
2020-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120002271/0001209191-20-002271-index.htm
2020-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120002279/0001209191-20-002279-index.htm
2020-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120002283/0001209191-20-002283-index.htm
2020-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120002285/0001209191-20-002285-index.htm
2020-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120002286/0001209191-20-002286-index.htm
2020-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120002287/0001209191-20-002287-index.htm
2020-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120002305/0001209191-20-002305-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120015098/0001209191-20-015098-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120015110/0001209191-20-015110-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120015120/0001209191-20-015120-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120015128/0001209191-20-015128-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120015140/0001209191-20-015140-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120015148/0001209191-20-015148-index.htm
2020-03-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120018851/0001209191-20-018851-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120023097/0001209191-20-023097-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120028249/0001209191-20-028249-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120032287/0001209191-20-032287-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120032291/0001209191-20-032291-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120036247/0001209191-20-036247-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120036251/0001209191-20-036251-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120036253/0001209191-20-036253-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120036257/0001209191-20-036257-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120036261/0001209191-20-036261-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120036265/0001209191-20-036265-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120036278/0001209191-20-036278-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120036282/0001209191-20-036282-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120038719/0001209191-20-038719-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120038722/0001209191-20-038722-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120038725/0001209191-20-038725-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120038727/0001209191-20-038727-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120038730/0001209191-20-038730-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120038731/0001209191-20-038731-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120042151/0001209191-20-042151-index.htm
2020-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120043107/0001209191-20-043107-index.htm
2020-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120043108/0001209191-20-043108-index.htm
2020-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120043111/0001209191-20-043111-index.htm
2020-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120043112/0001209191-20-043112-index.htm
2020-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120043119/0001209191-20-043119-index.htm
2020-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120043120/0001209191-20-043120-index.htm
2020-08-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120047746/0001209191-20-047746-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419600/000120919120047749/0001209191-20-047749-index.htm
2019-01-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000139077719000008/0001390777-19-000008-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000142284919000053/0001422849-19-000053-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1419600/000142284920000056/0001422849-20-000056-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459018019906/0001564590-18-019906-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1419600/000156459018019913/0001564590-18-019913-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459018027989/0001564590-18-027989-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1419600/000156459018027996/0001564590-18-027996-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459019000144/0001564590-19-000144-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459019000322/0001564590-19-000322-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459019005434/0001564590-19-005434-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1419600/000156459019005465/0001564590-19-005465-index.htm
2019-02-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1419600/000156459019005522/0001564590-19-005522-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1419600/000156459019013344/0001564590-19-013344-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1419600/000156459019013352/0001564590-19-013352-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459019017172/0001564590-19-017172-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1419600/000156459019017182/0001564590-19-017182-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459019023011/0001564590-19-023011-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459019029320/0001564590-19-029320-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1419600/000156459019029323/0001564590-19-029323-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459019041708/0001564590-19-041708-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1419600/000156459019041713/0001564590-19-041713-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459019045588/0001564590-19-045588-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459020000629/0001564590-20-000629-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459020010448/0001564590-20-010448-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1419600/000156459020010490/0001564590-20-010490-index.htm
2020-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1419600/000156459020010521/0001564590-20-010521-index.htm
2020-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459020014651/0001564590-20-014651-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1419600/000156459020019691/0001564590-20-019691-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1419600/000156459020019696/0001564590-20-019696-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459020022824/0001564590-20-022824-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1419600/000156459020022827/0001564590-20-022827-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459020026066/0001564590-20-026066-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459020029026/0001564590-20-029026-index.htm
2020-07-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459020032302/0001564590-20-032302-index.htm
2020-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459020032765/0001564590-20-032765-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459020036790/0001564590-20-036790-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1419600/000156459020036837/0001564590-20-036837-index.htm
2020-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459020040679/0001564590-20-040679-index.htm
2020-09-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1419600/000156459020043269/0001564590-20-043269-index.htm
2020-09-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1419600/000156459020043722/0001564590-20-043722-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459020046245/0001564590-20-046245-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419600/000156459020050450/0001564590-20-050450-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1419600/000156459020050458/0001564590-20-050458-index.htm
2020-11-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1419600/000156459020050593/0001564590-20-050593-index.htm
2020-09-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1419600/999999999520002508/9999999995-20-002508-index.htm
2018-10-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1419600/999999999718008383/9999999997-18-008383-index.htm
2019-07-12CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1419600/999999999719006126/9999999997-19-006126-index.htm

Flexion Therapeutics, Inc (FLXN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Flexion Therapeutics, Inc (FLXN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 434%
Institutional Ownership: 10439%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-23C ANN MERRIFIELDDirectorBuy8,000.0012.64101,120.0010,000.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119032582/0001209191-19-032582-index.htm
2020-01-03Neil BodickChief Scientific OfficerSell3,851.00100,153.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120002271/0001209191-20-002271-index.htm
2019-03-01Neil BodickChief Scientific OfficerBuy36,000.00100,782.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119016492/0001209191-19-016492-index.htm
2019-10-06Neil BodickChief Scientific OfficerBuy4,568.00105,350.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119052748/0001209191-19-052748-index.htm
2019-01-03Kerry WentworthChief Regulatory OfficerSell622.0012.367,687.9211,207.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119002084/0001209191-19-002084-index.htm
2020-07-16Mark S. LevineGeneral CounselBuy38,750.00114,260.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120043108/0001209191-20-043108-index.htm
2020-05-07David ArkowitzChief Financial OfficerSell2,413.0010.8826,253.44117,068.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120028249/0001209191-20-028249-index.htm
2020-06-22David ArkowitzChief Financial OfficerBuy1,303.0010.8314,111.49118,371.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120038730/0001209191-20-038730-index.htm
2020-03-02David ArkowitzChief Financial OfficerBuy31,000.00119,481.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120015120/0001209191-20-015120-index.htm
2020-07-16SCOTT KELLEYChief Medical OfficerBuy38,750.00119,710.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120043119/0001209191-20-043119-index.htm
2020-07-16Kerry WentworthChief Regulatory OfficerBuy38,750.00120,180.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120043107/0001209191-20-043107-index.htm
2020-07-16Christina WillwerthChief Strategy OfficerBuy38,750.00121,788.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120043112/0001209191-20-043112-index.htm
2020-06-10C ANN MERRIFIELDDirectorBuy4,500.0014,500.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120036261/0001209191-20-036261-index.htm
2019-01-03SCOTT KELLEYChief Medical OfficerSell622.0012.367,687.9215,271.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119002079/0001209191-19-002079-index.htm
2020-07-16David ArkowitzChief Financial OfficerBuy38,750.00157,121.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120043120/0001209191-20-043120-index.htm
2020-07-16Michael D. ClaymanPresident and CEOBuy93,750.00160,010.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120043111/0001209191-20-043111-index.htm
2020-05-26Mark StejbachDirectorBuy2,051.009.7519,997.252,051.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120032291/0001209191-20-032291-index.htm
2020-07-09ALAN MILINAZZODirectorBuy18,450.002.2040,499.6022,950.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120042151/0001209191-20-042151-index.htm
2020-06-10SAMUEL D COLELLADirectorBuy4,500.0030,004.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120036251/0001209191-20-036251-index.htm
2019-08-29PATRICK J MAHAFFYDirectorBuy30,824.000.164,931.8430,824.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119047709/0001209191-19-047709-index.htm
2020-05-26Michael D. ClaymanPresident and CEOBuy10,256.009.7599,996.00346,605.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120032287/0001209191-20-032287-index.htm
2020-06-10PATRICK J MAHAFFYDirectorBuy4,500.0035,324.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120036278/0001209191-20-036278-index.htm
2020-01-03Mark S. LevineGeneral CounselSell3,724.0043,487.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120002285/0001209191-20-002285-index.htm
2018-08-09David ArkowitzChief Financial OfficerBuy4,000.0023.4293,680.0044,250.00https://www.sec.gov/Archives/edgar/data/1419600/000120919118046163/0001209191-18-046163-index.htm
2020-06-10ALAN MILINAZZODirectorBuy4,500.004,500.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120036265/0001209191-20-036265-index.htm
2020-06-10Heath LukatchDirectorBuy4,500.004,500.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120036253/0001209191-20-036253-index.htm
2020-06-10Sandesh MahatmeDirectorBuy4,500.004,500.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120036257/0001209191-20-036257-index.htm
2020-06-10Scott A CanuteDirectorBuy4,500.004,500.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120036247/0001209191-20-036247-index.htm
2019-03-01Mark S. LevineGeneral CounselBuy36,000.0045,060.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119016506/0001209191-19-016506-index.htm
2019-08-08SAMUEL D COLELLADirectorBuy2,000.0010.7421,480.0045,333.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119045325/0001209191-19-045325-index.htm
2019-06-21Mark S. LevineGeneral CounselBuy1,213.009.8111,899.5346,273.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119038762/0001209191-19-038762-index.htm
2018-11-09David ArkowitzChief Financial OfficerBuy4,000.0016.5666,221.6048,250.00https://www.sec.gov/Archives/edgar/data/1419600/000120919118058085/0001209191-18-058085-index.htm
2020-01-03SCOTT KELLEYChief Medical OfficerSell3,724.0049,365.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120002286/0001209191-20-002286-index.htm
2020-01-03Kerry WentworthChief Regulatory OfficerSell3,724.0050,061.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120002283/0001209191-20-002283-index.htm
2019-03-01Kerry WentworthChief Regulatory OfficerBuy36,000.0050,607.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119016930/0001209191-19-016930-index.htm
2019-06-21Kerry WentworthChief Regulatory OfficerBuy389.009.813,816.0950,996.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119038761/0001209191-19-038761-index.htm
2019-03-01SCOTT KELLEYChief Medical OfficerBuy36,000.0051,271.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119016755/0001209191-19-016755-index.htm
2020-01-03Christina WillwerthChief Strategy OfficerSell3,533.0052,473.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120002287/0001209191-20-002287-index.htm
2019-06-21SCOTT KELLEYChief Medical OfficerBuy2,152.009.8121,111.1253,423.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119038759/0001209191-19-038759-index.htm
2019-10-06Kerry WentworthChief Regulatory OfficerBuy3,400.0054,396.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119052756/0001209191-19-052756-index.htm
2019-03-01Christina WillwerthChief Strategy OfficerBuy36,000.0058,419.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119016512/0001209191-19-016512-index.htm
2020-04-01Melissa LaymanChief Commercial OfficerBuy61,000.0061,000.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120023097/0001209191-20-023097-index.htm
2018-07-03Neil BodickChief Scientific OfficerSell16,492.0025.00412,300.0062,307.00https://www.sec.gov/Archives/edgar/data/1419600/000120919118040937/0001209191-18-040937-index.htm
2019-01-03Neil BodickChief Scientific OfficerSell746.0012.369,220.5664,782.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119002070/0001209191-19-002070-index.htm
2020-06-10Mark StejbachDirectorBuy4,500.006,551.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120036282/0001209191-20-036282-index.htm
2020-06-22Michael D. ClaymanPresident and CEOBuy1,303.0010.8314,111.4966,260.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120038727/0001209191-20-038727-index.htm
2019-01-03Michael D. ClaymanPresident and CEOSell3,278.0012.3640,516.0866,810.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119002065/0001209191-19-002065-index.htm
2018-10-08Neil BodickChief Scientific OfficerBuy4,566.0066,873.00https://www.sec.gov/Archives/edgar/data/1419600/000120919118054551/0001209191-18-054551-index.htm
2019-08-13Christina WillwerthChief Strategy OfficerBuy8,750.000.161,400.0067,169.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119045884/0001209191-19-045884-index.htm
2018-11-09Michael D. ClaymanPresident and CEOBuy5,000.0017.1085,476.5069,166.00https://www.sec.gov/Archives/edgar/data/1419600/000120919118058086/0001209191-18-058086-index.htm
2019-03-12Michael D. ClaymanPresident and CEOBuy4,046.0012.3650,008.5670,856.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119019135/0001209191-19-019135-index.htm
2019-06-21Michael D. ClaymanPresident and CEOBuy1,492.009.8114,636.5271,424.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119038817/0001209191-19-038817-index.htm
2019-08-08Michael D. ClaymanPresident and CEOBuy2,317.0010.8525,136.2172,249.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119045123/0001209191-19-045123-index.htm
2020-03-02Mark S. LevineGeneral CounselBuy31,000.0074,487.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120015128/0001209191-20-015128-index.htm
2019-05-10Michael D. ClaymanPresident and CEOBuy4,012.0012.4850,067.3574,868.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119029182/0001209191-19-029182-index.htm
2018-08-09Michael D. ClaymanPresident and CEOBuy10,000.0022.33223,300.0075,282.00https://www.sec.gov/Archives/edgar/data/1419600/000120919118046129/0001209191-18-046129-index.htm
2020-06-22Mark S. LevineGeneral CounselBuy1,023.0010.8311,079.0975,510.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120038722/0001209191-20-038722-index.htm
2018-07-02Neil BodickChief Scientific OfficerSell33,508.0025.10841,191.5378,799.00https://www.sec.gov/Archives/edgar/data/1419600/000120919118040937/0001209191-18-040937-index.htm
2020-03-02SCOTT KELLEYChief Medical OfficerBuy31,000.0080,365.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120015110/0001209191-20-015110-index.htm
2020-06-22SCOTT KELLEYChief Medical OfficerBuy595.0010.836,443.8580,960.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120038725/0001209191-20-038725-index.htm
2020-03-02Kerry WentworthChief Regulatory OfficerBuy31,000.0081,061.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120015140/0001209191-20-015140-index.htm
2020-06-22Kerry WentworthChief Regulatory OfficerBuy369.0010.833,996.2781,430.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120038719/0001209191-20-038719-index.htm
2019-05-08David ArkowitzChief Financial OfficerSell2,248.0010.0622,614.8882,924.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119028497/0001209191-19-028497-index.htm
2020-03-02Christina WillwerthChief Strategy OfficerBuy31,000.0083,473.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120015148/0001209191-20-015148-index.htm
2019-03-01David ArkowitzChief Financial OfficerBuy36,000.0085,172.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119016498/0001209191-19-016498-index.htm
2019-05-13David ArkowitzChief Financial OfficerBuy4,000.0011.9947,960.0086,924.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119029970/0001209191-19-029970-index.htm
2019-10-06Michael D. ClaymanPresident and CEOBuy14,800.0087,049.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119052754/0001209191-19-052754-index.htm
2020-01-03David ArkowitzChief Financial OfficerSell3,095.0088,481.00https://www.sec.gov/Archives/edgar/data/1419600/000120919120002279/0001209191-20-002279-index.htm
2019-05-31David ArkowitzChief Financial OfficerBuy2,500.0011.0527,626.7589,424.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119033898/0001209191-19-033898-index.htm
2018-10-08Michael D. ClaymanPresident and CEOBuy14,800.0090,082.00https://www.sec.gov/Archives/edgar/data/1419600/000120919118054525/0001209191-18-054525-index.htm
2019-01-03Mark S. LevineGeneral CounselSell734.0012.369,072.249,060.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119002087/0001209191-19-002087-index.htm
2019-06-21David ArkowitzChief Financial OfficerBuy2,152.009.8121,111.1291,576.00https://www.sec.gov/Archives/edgar/data/1419600/000120919119038758/0001209191-19-038758-index.htm